Program Overview
The 2026 Breast Cancer Management CME will review state of the art practices in breast cancer risk assessment, screening and treatment, and discuss results from recently published clinical trials. The format will consist of lectures, panel discussion, a mock tumor board, where our internationally recognized faculty will present and review complex cases.
Learning Objectives
1. Discuss breast cancer risk stratification and use of advanced imaging, imaging-based risk and risk-adapted screening
2. Describe updates in the local management of breast cancer, including pre-operative radiation therapy and breast reconstruction
3. Discuss new advances in systemic therapies in the treatment of HER2-positive breast cancer and hormone receptor-positive breast cancer.
Target Audience
This program has been designed for primary care physicians, internists, gynecologists, general surgeons, medical oncologists, radiation oncologists, surgical oncologists, radiologists, nurses and other clinicians involved in the management and treatment of patients with breast cancer.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Columbia University. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
Amedco LLC designates this live activity for a maximum of 4.00 AMA PRA Category 1 Credits for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
Amedco LLC designates this activity for a maximum of 4.00 ANCC contact hours.
